We offer concurrent cisplatinum with EBRT to high grade or bulky vaginal diseasehttps://www.ncbi.nlm.nih.gov/pubmed/25241996

We offer enrollment to the current NRG trial which randomizes to RT plus or minus sensitizing platinum chemotherapy. Off of trial, I having been treating with RT alone. 

I agree with Dr Kharofa that enrolling patients to GOG-0238 is the right thing to do providing that one has this protocol open in their institution. Off protocol, we tailor our approach according to the extent of disease at recurrence. Patients who have a recurrence found on a smear but no evidence...